Viking Therapeutics (VKTX) had the highest return between July 23, 2018 and September 18, 2018 by a mid-cap US stock, returning 71.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 7/23/2018 - 9/18/2018 | 71.91% |
Scholar Rock (SRRK) | 7/23/2018 - 9/18/2018 | 65.98% |
Bloom Energy (BE) | 7/23/2018 - 9/18/2018 | 60% |
AeroVironment (AVAV) | 7/23/2018 - 9/18/2018 | 59.2% |
Geron (GERN) | 7/23/2018 - 9/18/2018 | 57.76% |
Tandem Diabetes Care (TNDM) | 7/23/2018 - 9/18/2018 | 57.01% |
Match (MTCH) | 7/23/2018 - 9/18/2018 | 56.38% |
Denali Therapeutics (DNLI) | 7/23/2018 - 9/18/2018 | 52.34% |
Glaukos (GKOS) | 7/23/2018 - 9/18/2018 | 48.18% |
IAC (IAC) | 7/23/2018 - 9/18/2018 | 45.83% |
United Parks & Resorts (PRKS) | 7/23/2018 - 9/18/2018 | 41.39% |
Workiva (WK) | 7/23/2018 - 9/18/2018 | 41.34% |
Paycom Soft (PAYC) | 7/23/2018 - 9/18/2018 | 41.14% |
Smartsheet (SMAR) | 7/23/2018 - 9/18/2018 | 39.5% |
CarGurus (CARG) | 7/23/2018 - 9/18/2018 | 39.18% |
Crinetics Pharmaceuticals (CRNX) | 7/23/2018 - 9/18/2018 | 37.25% |
Mercury Systems (MRCY) | 7/23/2018 - 9/18/2018 | 37.18% |
Xenon Pharmaceuticals (XENE) | 7/23/2018 - 9/18/2018 | 36.32% |
ADMA Biologics (ADMA) | 7/23/2018 - 9/18/2018 | 33.95% |
Flowserve (FLS) | 7/23/2018 - 9/18/2018 | 33.65% |
United States Cellular (USM) | 7/23/2018 - 9/18/2018 | 32.19% |
Appfolio (APPF) | 7/23/2018 - 9/18/2018 | 31.96% |
Goosehead Insurance (GSHD) | 7/23/2018 - 9/18/2018 | 31.9% |
Five9 (FIVN) | 7/23/2018 - 9/18/2018 | 30.77% |
ICL Israel Chemicals (ICL) | 7/23/2018 - 9/18/2018 | 30.5% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
